AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: Kanuma (Alexion Pharmaceuticals) (kanuma.com)
This site is a regulatory fortress that prioritizes pharmacovigilance over marketing. It contains the minimum amount of bullshit possible for a commercial pharmaceutical entity, with its only minor failings being stale reference dates and a lack of modern technical schema.
Implement Organization and Brand schema to link the product to Alexion and AstraZeneca’s official digital identities. Update clinical references to include more recent real-world evidence or post-market surveillance data from 2024 or 2025 to refresh the stale 2022 citations. Replace the generic support clichés in the OneSource section with specific metrics, such as average time to treatment or number of advocacy groups partnered with. Ensure the Prescribing Information links are reflected as verifiable proof paths in the site’s metadata.
Information density is exceptionally high for the category. The text avoids fluff-heavy power words in headings, opting for functional descriptors like Dosing, Indication, and Important Safety Information. Body substance is anchored by specific clinical trial percentages, such as the 3 percent of infants experiencing anaphylaxis and the 30 percent threshold for specific side effects like diarrhea and anemia. Repetition is limited to legally required safety disclosures and the OneSource support program details.
A validator checks tags. An AI system checks whether your identity is stable across all crawl paths. Start your free canonical interpretation to see how your URLs are actually resolved by LLMs.
There is virtually zero semantic drift between the homepage signal and sub-page substance. The homepage H1 claims it is the only FDA-approved treatment for LAL-D, and the HCP sub-page provides the technical Package Insert references and Dosing guidelines to substantiate that claim. The messaging transition from patient-centric support on the homepage to professional clinical data on the HCP page is logically consistent and maintains the same technical definitions of sebelipase alfa.
Move beyond vague agency reporting and visualize your surgical implementation plan. Order an Executive SEO Strategy and stop relying on superficial keyword tracking.
The site avoids common trust theatre patterns like unverified customer reviews; the review_count is 0. However, the primary clinical reference is dated January 11, 2022, which is over 52 months old relative to the May 2026 anchor, making the evidence technically stale. While the proof_links_count is 0 in the metadata, the text provides clear paths to the full Prescribing Information and references the US National Library of Medicine DailyMed database.
The proof density is high, with a significant ratio of technical specifications to vague assertions. Specific adverse reaction data (e.g., 21 of 106 patients experiencing hypersensitivity) provides forensic-level proof of the drug’s clinical profile. The only missing element is a more current set of real-world evidence or post-market surveillance data beyond the 2022 baseline.
To see how the methodology translates into real diagnostic output, review a full executive level analysis applied to a global fashion retailer. View the Mango Executive SEO Strategy for a concrete example of how structural gaps, semantic weaknesses, and conversion friction are surfaced in practice.
The site exhibits standard pharmaceutical commodity patterns, particularly in the OneSource support section. Phrases like supported every step of the way and you will never have to go it alone are industry clichés found in nearly every rare-disease patient program. The template fingerprints for Healthcare Professionals and Patient Resources are standard for the sector, though the specific clinical data prevents these sections from being purely generic.
Authority is established through regulatory compliance rather than individual expertise. There is a gap in structured data as schema_json is null across the provided pages, and there are no sameAs links to the parent organization (Alexion) or specific medical directors. While the brand authority is high due to the FDA-approved status, the digital identity footprint via schema is absent.
The site makes no bold, unsubstantiated marketing claims. Every performance claim regarding the drug’s efficacy is tethered to the KANUMA Package Insert and clinical trial observations. The disconnect is minimal, as the marketing tone is heavily suppressed by the required safety and risk documentation.
Medical Devices, Pharma & Biotech BS: Kanuma (Alexion Pharmaceuticals) (kanuma.com)
The content perfectly aligns with the Pharma & Biotech category. It adheres to strict FDA-mandated structures including Boxed Warnings, Indication statements, and clinical adverse reaction data.
Every pillar of machine readability depends on one foundation: explicit, verifiable entity definitions. Explore the Structured Data Technical Framework to understand how identity, relationships, and @id anchors form the base layer of AI interpretation.
“The score of 17 is driven primarily by the high information density and lack of semantic drift. Small penalties were applied in the Trust and Proof pillar due to the 52-month delta on clinical references (stale evidence) and the absence of technical schema in Identity and Authority.”
Analysis Disclosure & Source Attribution
Snapshot Date: May 27, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at Kanuma (Alexion Pharmaceuticals) to view the most current version of their content and see directly what the company offers.